The DOI matches its Crossref record; 31 of the 34 references it cites were found in a registry or an index.
Disease-Specific Induced Pluripotent Stem Cells.
Open accessAbstract
Tissue culture of immortal cell strains from diseased patients is an invaluable resource for medical research but is largely limited to tumor cell lines or transformed derivatives of native tissues. Here we describe the generation of induced pluripotent stem (iPS) cells from patients with a variety of genetic diseases with either Mendelian or complex inheritance; these diseases include adenosine deaminase deficiency-related severe combined immunodeficiency (ADA-SCID), Shwachman-Bodian-Diamond syndrome (SBDS), Gaucher disease (GD) type III, Duchenne (DMD) and Becker muscular dystrophy (BMD), Parkinson disease (PD), Huntington disease (HD), juvenile-onset, type 1 diabetes mellitus (JDM), Down syndrome (DS)/trisomy 21, and the carrier state of Lesch-Nyhan syndrome. Such disease-specific stem cells offer an unprecedented opportunity to recapitulate both normal and pathologic human tissue formation in vitro, thereby enabling disease investigation and drug development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“The first iPSCs reprogrammed from an individual with DS were reported in 2008 (Park et al., 2008) and multiple lines have been created from multiple different individuals since then.”
From Neurodevelopment in Down syndrome: Concordance in humans and models (2022) · cites this paper as Park et al., 2008
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Induction of pluripotent stem cells from adult human fibroblasts by defined factors.
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/s0093-3619(08)70915-8 · Cited by 19,664 · cited 2×
“In contrast, introducing a set of transcription factors linked to pluripotency can directly reprogram human somatic cells to produce induced pluripotent stem (iPS) cells, a method that has been achieved by several groups worldwide (Lowry et al., 2008; Park et al., 2008b; Takahashi et al., 2007; Yu et al., 2007).”
Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells
Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R., et al. (2007) · Science · doi:10.1126/science.1151526 · Cited by 10,310 · cited 2×
“In contrast, introducing a set of transcription factors linked to pluripotency can directly reprogram human somatic cells to produce induced pluripotent stem (iPS) cells, a method that has been achieved by several groups worldwide (Lowry et al., 2008; Park et al., 2008b; Takahashi et al., 2007; Yu et al., 2007).”
Reprogramming of human somatic cells to pluripotency with defined factors
Park, I.-H., Zhao, R., West, J. A., Yabuuchi, A., Huo, H., Ince, T. A., Lerou, P. H., Lensch, M. W., & Daley, G. Q. (2008) · Nature · doi:10.1038/nature06534 · Cited by 2,436 · cited 12×
“Following 2 to 3 weeks of culture in hES cell-supporting conditions, compact refractile ES-like colonies emerged among a background of fibroblasts, as previously described (Park et al., 2008a, 2008b).”
InfluentialSelf-citationSite-directed mutagenesis by gene targeting in mouse embryo-derived stem cells
Thomas, K. R., & Capecchi, M. R. (1987) · Cell · doi:10.1016/0092-8674(87)90646-5 · Cited by 2,355 · cited 1×
“Strategies for inducing specific mutation or gene repair by homologous recombination were first established for the HPRT locus (Doetschman et al., 1987, 1988; Thomas and Capecchi, 1987).”
Murry, C. E., & Keller, G. M. (2008) · Cell · doi:10.1016/j.cell.2008.02.008 · Cited by 1,760 · cited 1×
“Human embryonic stem cells isolated from excess embryos from in vitro fertilization clinics represent an immortal propagation of pluripotent cells that theoretically can generate any cell type within the human body (Lerou et al., 2008; Murry and Keller, 2008).”
Deletion screening of the Duchenne muscular dystrophy locus via multiplex DNA amplification
Chamberlain, J. S., Gibbs, R. A., Rainer, J. E., Nguyen, P. N., & Caskey, C. T. (1988) · Nucleic Acids Research · doi:10.1093/nar/16.23.11141 · Cited by 1,271 · cited 2×
“Multiplex PCR analysis with primer sets amplifying several (but not all) intragenic intervals of the dystrophin gene (Beggs et al., 1990; Chamberlain et al., 1988) revealed the deletion of exons 45–52 in the iPS cells derived from a patient with Duchenne muscular dystrophy (DMD; Figure 1C).”
Generation of human induced pluripotent stem cells from dermal fibroblasts
Lowry, W. E., Richter, L., Yachechko, R., Pyle, A. D., Tchieu, J., Sridharan, R., Clark, A. T., & Plath, K. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711983105 · Cited by 1,041 · cited 2×
“In contrast, introducing a set of transcription factors linked to pluripotency can directly reprogram human somatic cells to produce induced pluripotent stem (iPS) cells, a method that has been achieved by several groups worldwide (Lowry et al., 2008; Park et al., 2008b; Takahashi et al., 2007; Yu et al., 2007).”
Sequential Expression of Pluripotency Markers during Direct Reprogramming of Mouse Somatic Cells
Brambrink, T., Foreman, R. K., Welstead, G. G., Lengner, C. J., Wernig, M., Suh, H., & Jaenisch, R. (2008) · Cell stem cell · doi:10.1016/j.stem.2008.01.004 · Cited by 839 · cited 2×
“…from a carrier of Lesch-Nyhan syndrome using five doxycycline-inducible lentiviral vectors (OCT4, SOX2, KLF4, c-MYC, and NANOG), a strategy that has been used to isolate murine iPS cells (Brambrink et al., 2008; Stadtfeld et al., 2008) but previously had not been attempted with human somatic cells.”
Defining molecular cornerstones during fibroblast to iPS cell reprogramming in mouse
Stadtfeld, M., Maherali, N., Breault, D. T., & Hochedlinger, K. (2008) · Cell stem cell · doi:10.1016/j.stem.2008.02.001 · Cited by 823 · cited 4×
“…from a carrier of Lesch-Nyhan syndrome using five doxycycline-inducible lentiviral vectors (OCT4, SOX2, KLF4, c-MYC, and NANOG), a strategy that has been used to isolate murine iPS cells (Brambrink et al., 2008; Stadtfeld et al., 2008) but previously had not been attempted with human somatic cells.”
MethodInfluentialSelf-citationNon–cell autonomous effect of glia on motor neurons in an embryonic stem cell–based ALS model
Di Giorgio, F. P., Carrasco, M. A., Siao, M. C., Maniatis, T., & Eggan, K. (2007) · Nature Neuroscience · doi:10.1038/nn1885 · Cited by 799
Targetted correction of a mutant HPRT gene in mouse embryonic stem cells
Doetschman, T., Gregg, R., Maeda, N., Hooper, M., Melton, D., Thompson, S., & Smithies, O. (1987) · Nature · doi:10.1038/330576a0 · Cited by 756 · cited 1×
“Strategies for inducing specific mutation or gene repair by homologous recombination were first established for the HPRT locus (Doetschman et al., 1987, 1988; Thomas and Capecchi, 1987).”
Chromosome 21 and Down syndrome: from genomics to pathophysiology
Antonarakis, S. E., Lyle, R., Dermitzakis, E. T., Reymond, A., & Deutsch, S. (2004) · Nature Reviews Genetics · doi:10.1038/nrg1448 · Cited by 703 · cited 3×
“…Building 7214, 300 Longwood Avenue, Boston, MA 02115 2Massachusetts General Hospital Cancer Center and Center for Regenerative Medicine and Department of Stem Cell and Regenerative Biology, 185 Cambridge Street, Boston, MA 02114, USA 3Department of Molecular and Cellular Biology, Harvard…”
InfluentialCorrection of a genetic defect by nuclear transplantation and combined cell and gene therapy.
Rideout, W., Hochedlinger, K., Kyba, M., Daley, G., & Jaenisch, R. (2002) · Cell · doi:10.1016/s0092-8674(02)00681-5 · Cited by 624 · cited 1×
“In a proof of principle experiment, NT-embryonic stem (ES) cells generated from mice with genetic immunodeficiency were used to combine gene and cell therapy to repair the genetic defect (Rideout et al., 2002).”
Self-citationThe four ages of Down syndrome.
Bittles, A., Bower, C., Hussain, R., & Glasson, E. (2007) · European Journal of Public Health · doi:10.1093/eurpub/ckl103 · Cited by 505 · cited 1×
“Some studies place the frequency of spontaneous fetal demise (miscarriage) in DS to be above 40% (Bittles et al., 2007).”
Generation of human-induced pluripotent stem cells
Park, I., Lerou, P. H., Zhao, R., Huo, H., & Daley, G. Q. (2008) · Nature Protocols · doi:10.1038/nprot.2008.92 · Cited by 410 · cited 7×
“Following 2 to 3 weeks of culture in hES cell-supporting conditions, compact refractile ES-like colonies emerged among a background of fibroblasts, as previously described (Park et al., 2008a, 2008b).”
InfluentialSelf-citationDetection of 98% of DMD/BMD gene deletions by polymerase chain reaction
Beggs, A., Koenig, M., Boyce, F., & Kunkel, L. (1990) · Human Genetics · doi:10.1007/bf00205170 · Cited by 404 · cited 2×
“Multiplex PCR analysis with primer sets amplifying several (but not all) intragenic intervals of the dystrophin gene (Beggs et al., 1990; Chamberlain et al., 1988) revealed the deletion of exons 45–52 in the iPS cells derived from a patient with Duchenne muscular dystrophy (DMD; Figure 1C).”
A Chromosome 21 Critical Region Does Not Cause Specific Down Syndrome Phenotypes
Olson, L. E., Richtsmeier, J. T., Leszl, J. M., & Reeves, R. H. (2004) · Science · doi:10.1126/science.1098992 · Cited by 331 · cited 2×
“A mouse model for the DS critical region on distal human chromosome 21 fails to recapitulate the human cranial abnormalities commonly associated with trisomy 21 (Olson et al., 2004).”
Chen, M., Tomkins, D., Auerbach, W., McKerlie, C., Youssoufian, H., Liu, L., Gan, O., Carreau, M., Auerbach, A., Groves, T., et al. (1996) · Nature Genetics · doi:10.1038/ng0496-448 · Cited by 274 · cited 1×
“Murine strains carrying the same genetic deficiencies as the human bone marrow failure disease Fanconi anemia demonstrate DNA repair defects consistent with the human condition (e.g., Chen et al., 1996), yet none develop the spontaneous bone marrow failure that is the hallmark of the human disease.”
Targeted mutation of the Hprt gene in mouse embryonic stem cells.
Doetschman, T., Maeda, N., & Smithies, O. (1988) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.85.22.8583 · Cited by 212 · cited 2×
“Strategies for inducing specific mutation or gene repair by homologous recombination were first established for the HPRT locus (Doetschman et al., 1987, 1988; Thomas and Capecchi, 1987).”
Lensch, M. W., Schlaeger, T., Zon, L., & Daley, G. (2007) · Cell Stem Cell · doi:10.1016/j.stem.2007.07.019 · Cited by 180 · cited 1×
“The ultimate standard of pluripotency for human cells is teratoma formation in immunodeficient murine hosts (Lensch et al., 2007).”
Self-citationExperience and strategy for the molecular testing of Duchenne muscular dystrophy.
Prior, T., & Bridgeman, S. J. (2005) · Journal of Molecular Diagnostics · doi:10.1016/s1525-1578(10)60560-0 · Cited by 154 · cited 1×
“As BMD is a milder form of disease, and the dystrophin gene one of the largest in the human genome, definition of the genetic lesion responsible for this condition is sometimes elusive (Prior and Bridgeman, 2005).”
Beutler, E., Gelbart, T., Kuhl, W., Sorge, J. A., & West, C. (1991) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.88.23.10544 · Cited by 136 · cited 2×
“Molecular analysis of the GBA gene in the Gaucher disease line revealed a 1226A > G point mutation, causing a N370S amino acid substitution (Figure 1B); the second allele is known to have a frameshifting insertion of a single guanine at cDNA nucleotide 84 (84GG) (Beutler et al., 1991).”
Chong, S. S., Almqvist, E., Telenius, H., LaTray, L., Nichol, K., Bourdelat-Parks, B., Goldberg, Y., Haddad, B., Richards, F., Sillence, D., et al. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.2.301 · Cited by 122 · cited 2×
“…(Huntington disease; HD) and verified the presence of expanded (CAG)n polyglutamine triplet repeat sequences (72) in the proximal portion of the huntingtin gene (Figure 1C; Riess et al., 1993) in one allele and 19 repeats in the other (where the normal range is 35 or less; Chong et al., 1997).”
Nussbaum, R., Crowder, W. E., Nyhan, W., & Caskey, C. (1983) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.80.13.4035 · Cited by 108 · cited 1×
“The Lesch-Nyhan syndrome carrier line harbors heterozygous deficiency of the HPRT gene (Nussbaum et al., 1983).”
The art and design of genetic screens: mammalian culture cells
Grimm, S. (2004) · Nature reviews genetics · doi:10.1038/nrg1291 · Cited by 107 · cited 2×
“Most of the human cell lines in wide use today carry genetic and epigenetic artifacts of accommodation to tissue culture and are derived either from malignant tissues or are genetically modified to drive immortal growth (Grimm, 2004).”
Human embryonic stem cell derivation from poor-quality embryos
Lerou, P., Yabuuchi, A., Huo, H.-G., Takeuchi, A., Shea, J., Cimini, T., Ince, T., Ginsburg, E., Racowsky, C., & Daley, G. (2008) · Nature Biotechnology · doi:10.1038/nbt1378 · Cited by 102 · cited 1×
“Human embryonic stem cells isolated from excess embryos from in vitro fertilization clinics represent an immortal propagation of pluripotent cells that theoretically can generate any cell type within the human body (Lerou et al., 2008; Murry and Keller, 2008).”
Self-citationImproved PCR conditions for the stretch of (CAG)n repeats causing Huntington's disease.
Riess, O., Noerremoelle, A., Soerensen, S., & Epplen, J. (1993) · Human Molecular Genetics · doi:10.1093/hmg/2.6.637 · Cited by 94 · cited 2×
“We generated iPS cell lines from a patient with Huntington chorea (Huntington disease; HD) and verified the presence of expanded (CAG)n polyglutamine triplet repeat sequences (72) in the proximal portion of the huntingtin gene (Figure 1C; Riess et al., 1993) in one allele and 19 repeats in the other (where the normal…”
Mutations in the SBDS gene in acquired aplastic anemia
Calado, R. T., Graf, S. A., Wilkerson, K. L., Kajigaya, S., Ancliff, P., Dror, Y., Chanock, S. J., Lansdorp, P. M., & Young, N. S. (2007) · Blood · doi:10.1182/blood-2007-03-080044 · Cited by 75 · cited 2×
“tions were performed using 50 ng of genomic DNA with primers corresponding to the mutated regions of genes responsible for each condition (ADA-SCID, GD, SBDS [ Calado et al., 2007 ], and HD).”
Human embryonic stem cell lines with genetic disorders.
Verlinsky, Y., Strelchenko, N., Kukharenko, V., Rechitsky, S., Verlinsky, O., Galat, V., & Kuliev, A. (2005) · Reproductive Biomedicine Online · doi:10.1016/s1472-6483(10)60810-3 · Cited by 65 · cited 2×
“…genetic diagnosis (PGD; genetic analysis of single blastomeres obtained by embryo biopsy) can yield stem cell lines that model single-gene disorders (Verlinsky et al., 2005), but the vast majority of diseases that show more complex genetic patterns of inheritance are not represented in this pool.”
The Critical Region in Trisomy 21
Nelson, D. L., & Gibbs, R. A. (2004) · Science · doi:10.1126/science.1105226 · Cited by 31 · cited 2×
“Orthologous segments to human chromosome 21 are present on mouse chromosomes 10 and 17, and distal human chromosome 21 corresponds to mouse chromosome 16 where trisomy 16 in the mouse is lethal (Nelson and Gibbs, 2004).”
The Shwachman-Diamond SBDS Protein Localizes to the Nucleolus
Stockman, J. (2007) · doi:10.1016/s0084-3954(08)70028-9 · Cited by 25 · cited 3×
“Bone marrow mesenchymal cells from SBDS patient (SBDS, DF250) have been described (Austin et al., 2005).”
Influential
Flagged first, then by citations
3 of the 34 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- Hirschhorn, 1993, Two new mutations at the adenosine deaminase (ADA) locus (Q254X and del nt1050–54) unusual for not being missense mutations, Hum. Mutat., 2, 320, 10.1002/humu.1380020415 · DOI
Cited by
Sorted by citations
The Science of Stroke: Mechanisms in Search of Treatments
Moskowitz, M. A., Lo, E. H., & Iadecola, C. (2010) · Neuron · doi:10.1016/j.neuron.2010.07.002 · Cited by 1,930
Huntington's disease: from molecular pathogenesis to clinical treatment
Ross, C. A., & Tabrizi, S. J. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70245-3 · Cited by 1,816
Soldner, F., Hockemeyer, D. F., Beard, C., Gao, Q., Bell, G. W., Cook, E. G., Hargus, G., Blak, A. A., Cooper, O., Mitalipova, M. M., et al. (2009) · Cell · doi:10.1016/j.cell.2009.02.013 · Cited by 1,584
“As reported previously with either lentiviral or Moloney-based retroviral vectors (Dimos et al., 2008; Ebert et al., 2009; Hockemeyer et al., 2008; Park et al., 2008a; Yu et al., 2007), we detected residual expression of the reprogramming factors for most of the transgenes in all cell lines with…”
BackgroundInfluentialFunctional Cardiomyocytes Derived From Human Induced Pluripotent Stem Cells
Zhang, J., Wilson, G. F., Soerens, A. G., Koonce, C. H., Yu, J., Palecek, S. P., Thomson, J. A., & Kamp, T. J. (2009) · Circulation Research · doi:10.1161/circresaha.108.192237 · Cited by 1,426
“H9 (4) Foreskin C1 (3) IMR90 C4 (5) 50 100 * * *”
Induced pluripotent stem cells from a spinal muscular atrophy patient
Ebert, A. D., Yu, J., Rose, F. F., Mattis, V. B., Lorson, C. L., Thomson, J. A., & Svendsen, C. N. (2009) · Nature · doi:10.1038/nature07677 · Cited by 1,441
Metadata
- Authors
- Park, I.-H., Arora, N., Huo, H., Maherali, N., Ahfeldt, T., Shimamura, A., Lensch, M. W., Cowan, C., Hochedlinger, K., & Daley, G. Q.
- Affiliations
- Boston Children's Hospital (US)
- Harvard University (US)
- University of Washington (US)
- Brigham and Women's Hospital (US)
- Corresponding author
- Daley, George Q.
- ORCID
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2008-09
- Volume
- 134
- Issue
- 5
- Pages
- 877-886
- ISSN
- 0092-8674 (ISSN-L)
- PMC
- PMC2633781
- OpenAlex
- W2157645703
- Cited by
- 2,196
- References
- 34
- Citations by year
- 2026: 20 · 2025: 32 · 2024: 38 · 2023: 51 · 2022: 62 · 2021: 75 · 2020: 89 · 2019: 73 · 2018: 71 · 2017: 108 · 2016: 125 · 2015: 144 · 2014: 139 · 2013: 204 · 2012: 272
- FWCI
- 95.00
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cell (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Howard Hughes Medical Institute
- National Institutes of Health (DP1OD000256)
- National Heart, Lung, and Blood Institute (R01HL079582)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK059279)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Keywords
- induced pluripotent stem cells, genetic disorders, Mendelian inheritance, multifactorial inheritance, ADA-SCID, Duchenne muscular dystrophy, Becker muscular dystrophy, Parkinson's disease, Huntington's disease, Down syndrome, Lesch-Nyhan syndrome, in vitro disease model, drug development
- MeSH terms
- Bone Marrow Cells, Cell Line, Fibroblasts, Humans, Karyotyping, Mutation, Genetic Diseases, Inborn, Pluripotent Stem Cells, Mesenchymal Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review